Literature DB >> 1245780

Radioimmunoassay of human C-reactive protein and levels in normal sera.

D R Claus, A P Osmand, H Gewurz.   

Abstract

C-reactive protein (CRP) has been considered an acute-phase protein which appears only during reactions of tissue injury or inflammation. We report here the quantitation of CRP levels in normal adults and neonates made possible by the development of a sensitive and precise radioimmunoassay for human CRP which enables the detection of 3 ng. per milliliter. Serum levels in 153 healthy blood donors ranged from 68 to 8,200 ng. per milliliter, with a median value of 580 ng. per milliliter (mean = 1,340 ng. per milliliter). CRP levels in 24 normal cord serum samples ranged from 10 to 370 ng. per milliliter, with a median value of 70 ng. per milliliter (mean = 109 ng. per milliliter). CRP levels in 246 individuals evaluated for autoimmune diseases ranged to 256,000 ng. per milliliter with a median value of 13,000 ng. per milliliter (mean = 38,000 ng. per milliliter). No individual lacking CRP was detected. Thus, CRP can be considered a component of normal serum which only increases dramatically in concentration during inflammation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245780

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  49 in total

1.  Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Haemophilus influenzae Increases Complement-Mediated Killing.

Authors:  Jeroen D Langereis; Eva S van der Pasch; Marien I de Jonge
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation.

Authors:  R E Chambers; C W Hutton; P A Dieppe; J T Whicher
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 3.  Immunoserology of infectious diseases.

Authors:  K James
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

4.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.

Authors:  Lelia H Chaisson; Fred C Semitala; Lucy Asege; Sandra Mwebe; Jane Katende; Martha Nakaye; Alfred O Andama; Carina Marquez; Elly Atuhumuza; Moses Kamya; Adithya Cattamanchi; Christina Yoon
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

6.  Comparison of serum C-reactive protein concentrations for laparoscopic versus open cholecystectomy.

Authors:  A Halevy; G Lin; R Gold-Deutsch; R Lavi; M Negri; S Evans; D Cotariu; J M Sackier
Journal:  Surg Endosc       Date:  1995-03       Impact factor: 4.584

7.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

8.  Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.

Authors:  I Kushner; M L Broder; D Karp
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Lymphocytes binding C-reactive protein during acute rheumatic fever.

Authors:  R C Williams; K A Kilpatrick; M Kassaby; Z H Abdin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus.

Authors:  Kirk W McCrea; Jingping Xie; Carl F Marrs; Janet R Gilsdorf
Journal:  BMC Microbiol       Date:  2010-11-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.